Aureli, A., Recupero, R., Mariani, M., Manco, M., Carlomagno, F., Bocchini, S., Nicodemo, M., Marchili, M
PMID 17498508
We report two female patients, aged 44 and 45 years, with long-standing CSU inadequately controlled on high-dose H1AH, who were initially prescreened for participation in a clinical trial with barzolvolimab
Mistake 3: obsessing over the scale Daily weigh-ins can be psychologically destructive during GLP-1 therapy
Nayan Patel Yes, for sure
By receipt of this publication, each recipient agrees that the information contained herein will be kept confidential and that the information will not be photocopied, reproduced, distributed to, or disclosed to others at any time without the prior written consent of Prime Therapeutics